CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-06 | WOOD LAUREN Chief Medical Officer | Grant or award · Stock Option (Right To Purchase) | +62,715 | 62,715 | ||
| 2019-06-06 | CONN GREGORY Chief Scientific Officer | Grant or award · Stock Option (Right To Purchase) | +40,000 | 40,000 | ||
| 2019-06-06 | Saik Andrew Chief Financial Officer | Grant or award · Stock Option (Right To Purchase) | +62,715 | 62,715 | ||
| 2019-03-15 | Macdonald R. Loch Director | Exercise or conversion | +10,000 | 580,602 | ||
| 2019-03-15 | Macdonald R. Loch Director | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2019-03-15 | Spiegel Robert J. Director | Exercise or conversion | +10,000 | 48,661 | ||
| 2019-03-15 | Spiegel Robert J. Director | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2019-03-15 | Saik Andrew Chief Financial Officer | Exercise or conversion | +82,999 | 82,999 | ||
| 2019-03-15 | Saik Andrew Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −82,999 | 0 | ||
| 2019-03-15 | Ratcliffe Liam Director | Exercise or conversion | +10,000 | 10,000 | ||
| 2019-03-15 | Ratcliffe Liam Director | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2019-03-15 | MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary | Exercise or conversion | +49,766 | 59,766 | ||
| 2019-03-15 | MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary | Exercise or conversion · Restricted Stock Units | −49,766 | 0 | ||
| 2019-03-15 | LOUGHLIN JAMES J Director | Exercise or conversion | +10,000 | 26,625 | ||
| 2019-03-15 | LOUGHLIN JAMES J Director | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2019-03-15 | Leuthner Brian A President and CEO | Exercise or conversion | +169,032 | 239,268 | ||
| 2019-03-15 | Leuthner Brian A President and CEO | Exercise or conversion · Restricted Stock Units | −169,032 | 0 | ||
| 2019-03-15 | BLECH ISAAC Director | Exercise or conversion | +10,000 | 10,000 | ||
| 2019-03-15 | BLECH ISAAC Director | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2019-03-15 | BLECH ISAAC Director | Exercise or conversion | +10,000 | 10,000 |
Page 7 of 18 · 346 trades